Back

Potential for delayed improvement of left ventricular ejection fraction in newly diagnosed heart failure under optimized therapy depends on etiology - data from the PROLONG-II study

3 April 2022 (08:20 - 20:00)
Organised by:
Congress Presentation Part of: ePosters Day 1 Implantable Cardioverter-Defibrillator (ICD) EHRA Premium Access EHRA 2022

About the speaker

Photo
Doctor Johanna Mueller-Leisse

Hannover Heart Rhythm Center, Hannover (Germany)

128 More presentations in this session

Presentation thumbnail
Detection of endo-epicardial atrial low-voltage areas using unipolar and omnipolar voltage mapping
Mr M. Van Schie (Rotterdam, NL)
Abstract Slides
Presentation thumbnail
Atrial high-rate episodes in patients with devices without a history of atrial fibrillation
Doctor I. Doundoulakis (Brussels, BE)
Abstract Slides
Presentation thumbnail
The impact of different fat depots in the body on the progression of atrial fibrillation - data from RACE V
Doctor V. Weberndoerfer (Maastricht, NL)
Abstract Slides
Presentation thumbnail
Pulsed field ablation of atrial fibrillation: recurrence rate after first pulmonary vein isolation and first insights into durability at redo procedures
Mr T. Kueffer (Bern, CH)
Abstract Slides
Presentation thumbnail
Early mortality and complications following first-time catheter ablation of atrial fibrillation in a nationwide cohort
Doctor C. Witt (Aarhus, DK)
Abstract Slides

Access the full session

Session thumbnail
ePosters Day 1

The Event

Event poster

EHRA 2022

3 April 2022 08:20 CET
You may be interested in
thumbnail
Congress Presentation
Late improvement of left ventricular ejection fraction in patients with persistent severe systolic dysfunction under guideline-directed medical therapy
11 December 2020
thumbnail
Congress Presentation
HFA-PEFF scoring of new onset idiopathic inflammatory myopathy patients reveals diastolic dysfunction
23 May 2023
thumbnail
Congress Presentation
Real world data on long-term clinical outcomes in heart failure patients with reduced ejection fraction and implantable cardioverter defibrillator
22 May 2023
thumbnail
Congress Presentation
Assessing the achievability of optimal therapy in patients with heart failure with reduced ejection fraction; a difficult task?
20 May 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources